Nanotechnology Conference and Trade Show - Nanotech 2006
> Program > Technical Conferences > Business & Development > Nano Impact Workshop > Nanotech Job Fair > Expo
Program
Sessions
Sunday
Monday
Tuesday
Wednesday
Thursday
Index of Authors
Index of Keywords
Confirmed Speakers
Conferences & Symposia

Conference Proceedings

Conference Technical Proceedings

EP Therapeutics

T.T. Chen
A-Round, US

Keywords:
pharma, biotech

Abstract:

An innovative approach to cancer therapy.

EP Therapeutics, Inc., (EPT) is engaged in the development of a revolutionary new class of cancer treatments that will provide safer alternative therapies by eliminating the need for chemotherapy or radiation protocols.The company is engaged in the development of new treatments for the management of epithelial cancers based on a unique, patented peptide (EPT-peptide). Numerous in vitro and in vivo studies have demonstrated that EPT-peptide and its gene possess properties that suppress growth, metastasis and angiogenesis and result in the induction of programmed cell death in many cancer types, including breast, ovary, colon, liver, brain and prostate. In addition, EPT-peptide possesses the attributes necessary for an ideal cancer treatment instrument.

Back to Program

Sessions Sunday Monday Tuesday Wednesday Thursday Authors

Nanotech 2006 Conference Program Abstract

 
Nanotechnology Conference | Terms of use | Privacy policy | Contact | NSTI Home
Program | Technical Conferences | Business & Development | Nano Impact Workshop | Nanotech Job Fair | Expo |
Nanotech 2006 Home | Press Room | Venue | Subscribe | Site Map
Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.